Cadrenal Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2023 to Q2 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cadrenal Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2023 to Q2 2025.
  • Cadrenal Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2025 was 384 %, a 52.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2025 384 -431 -52.8% Jun 30, 2025
Q1 2025 388 -692 -64.1% Mar 31, 2025
Q4 2024 435 -753 -63.4% Dec 31, 2024
Q3 2024 581 -91.2 -13.6% Sep 30, 2024
Q2 2024 815 Jun 30, 2024
Q1 2024 1.08K Mar 31, 2024
Q4 2023 1.19K Dec 31, 2023
Q3 2023 672 Sep 30, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.